148 related articles for article (PubMed ID: 37386821)
1. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-
Tae HS; Ortells MO; Tekarli BJ; Manetti D; Romanelli MN; McIntosh JM; Adams DJ; Arias HR
ACS Chem Neurosci; 2023 Jul; 14(14):2537-2547. PubMed ID: 37386821
[TBL] [Abstract][Full Text] [Related]
2. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA
Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR
Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.
Arias HR; Vázquez-Gómez E; Hernández-Abrego A; Gallino S; Feuerbach D; Ortells MO; Elgoyhen AB; García-Colunga J
Int J Biochem Cell Biol; 2018 Jul; 100():1-10. PubMed ID: 29704625
[TBL] [Abstract][Full Text] [Related]
5. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
6. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
[TBL] [Abstract][Full Text] [Related]
7. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
[TBL] [Abstract][Full Text] [Related]
8. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT
Arias HR; Rudin D; Hines DJ; Contreras A; Gulsevin A; Manetti D; Anouar Y; De Deurwaerdere P; Meiler J; Romanelli MN; Liechti ME; Chagraoui A
Eur J Pharmacol; 2024 Mar; 966():176329. PubMed ID: 38253116
[TBL] [Abstract][Full Text] [Related]
9. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
10. Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.
Quek GX; Lin D; Halliday JI; Absalom N; Ambrus JI; Thompson AJ; Lochner M; Lummis SC; McLeod MD; Chebib M
ACS Chem Neurosci; 2010 Dec; 1(12):796-809. PubMed ID: 22778816
[TBL] [Abstract][Full Text] [Related]
11. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
[TBL] [Abstract][Full Text] [Related]
12. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
Giraudo A; Pallavicini M; Bolchi C
Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412
[TBL] [Abstract][Full Text] [Related]
13. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Compound Targeting α7 and β2 Subunits in Nicotinic Acetylcholinergic Receptor.
Singh K; Ngo A; Keerthisinghe OV; Patel KK; Liang C; Mukherjee J
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138615
[TBL] [Abstract][Full Text] [Related]
15. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
16. Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism.
George AA; John SJ; Lucero LM; Eaton JB; Jaiswal E; Christensen SB; Gajewiak J; Watkins M; Cao Y; Olivera BM; Im W; McIntosh JM; Whiteaker P
FASEB J; 2024 Jan; 38(1):e23374. PubMed ID: 38161283
[TBL] [Abstract][Full Text] [Related]
17. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
18. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
[TBL] [Abstract][Full Text] [Related]
19. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
Li Q; Nemecz Á; Aymé G; Dejean de la Bâtie G; Prevost MS; Pons S; Barilone N; Baachaoui R; Maskos U; Lafaye P; Corringer PJ
Cell Mol Life Sci; 2023 May; 80(6):164. PubMed ID: 37231269
[TBL] [Abstract][Full Text] [Related]
20. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
